Delivery Order SPE2DB24D3013-SPE2DB25FFKCE
Award Date 3/11/25
Potential Completion Date 3/12/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of November 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The $3,361.87 Firm Fixed Price contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a prescription medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through 2025, to...
- This federal contract award, valued at $2,474.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The period of performance runs through September 27, 2024. The contract is not set aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- This federal contract award, valued at $1,908.00, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of May 6, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- This federal contract award, worth $2,893.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML 12S, a pharmaceutical product, with a period of performance through December 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a delivery order for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract is a firm fixed-price type, with a period of performance through February 18, 2025. Amerisourcebergen Drug Corp is a for-profit organization that has been registered in the System for Award Management (SAM.gov) since...
- This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company has been...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a Firm Fixed Price Delivery Order for the supply of COPAXONE 40 MG/ML syringes. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $1,711.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for COPAXONE 20 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of July 9, 2024. The contract has a firm fixed price pricing type and is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...